[HTML][HTML] Diabetes mellitus is associated with an increased risk of unsuccessful treatment outcomes among drug-susceptible tuberculosis patients in Ethiopia: A …

HT Adane, RC Howe, L Wassie, MJ Magee - Journal of Clinical …, 2023 - Elsevier
Background The impact of diabetes mellitus on tuberculosis (TB) treatment outcomes has
not been well investigated in most sub-Saharan countries including Ethiopia. The current …

The impact of comorbidities on tuberculosis treatment outcomes in Poland: a national cohort study

A Nowiński, S Wesołowski… - Frontiers in Public …, 2023 - frontiersin.org
Background Tuberculosis (TB) is a complex disease associated with other medical
conditions, that may affect disease severity. This study aimed to investigate the impact of …

Association between diabetes mellitus and cause of death in patients with tuberculosis: A Korean nationwide cohort study

SH Kwak, D Jeong, J Mok, D Jeon, HY Kang, HJ Kim… - PloS one, 2023 - journals.plos.org
Despite its significant impact on mortality, tuberculosis (TB)-diabetes mellitus (DM) co-
prevalence has not been well-elucidated for the cause of death. We investigated the impact …

Immunological aspects of host–pathogen crosstalk in the co-pathogenesis of diabetes and latent tuberculosis

A Verma, M Kaur, P Luthra, L Singh… - Frontiers in Cellular …, 2023 - frontiersin.org
Introduction Diabetes is a potent risk factor for the activation of latent tuberculosis and
worsens the tuberculosis (TB) treatment outcome. The major reason for mortality and …

[HTML][HTML] Point-of-care glycated hemoglobin a1c testing for the identification of hyperglycemia severity among individuals with dual tuberculosis and diabetes mellitus in …

KC Byashalira, NG Chamba, Y Alkabab… - The International …, 2023 - journals.lww.com
Background: Poor glycemic control during tuberculosis (TB) treatment is challenging, as the
optimum treatment strategy remains unclear. We assessed hyperglycemia severity using …

The TuberXpert project protocol: Towards a Clinical Decision Support System for therapeutic anti-tuberculosis medical drugs monitoring in Tanzania

Y Thoma, A Cathignol, Y Petermann, M Sariko, B Said… - medRxiv, 2023 - medrxiv.org
Introduction: The End Tuberculosis (TB) Strategy requires a novel patient treatment
approach contrary to the" one-size fits all" model. It is well known that each patient's …

Diabetes Mellitus and Tuberculosis Treatment Outcomes: Interaction Assessment Between Hyperglycemia and Human Immunodeficiency Virus in the State of Georgia …

K Houck, T Chakhaia, S Gorvetzian… - Open Forum …, 2023 - academic.oup.com
Background Diabetes mellitus and human immunodeficiency virus (HIV) are independent
risk factors for poor outcomes among people with tuberculosis (TB). To date, information on …

Factors Associated with Tuberculosis Treatment Outcomes among Patients in Mombasa County

GM Barako - 2023 - ir.jkuat.ac.ke
Tuberculosis is caused by the bacterium Mycobacterium tuberculosis, which is an air born
disease transmitted from person to person by aerosolized droplet nuclei. It typically affects …

[HTML][HTML] HIV co-infection increases the risk of post-tuberculosis mortality among persons who initiated treatment for drug-resistant tuberculosis

AD Salindri, M Kipiani, N Lomtadze, N Tukvadze… - medRxiv, 2023 - ncbi.nlm.nih.gov
Little is known regarding the relationship between common comorbidities in persons with
tuberculosis (TB)(including human immunodeficiency virus [HIV], diabetes, and hepatitis C …

Progress in Epidemiology of Tuberculosis in China

W Lu, L Zhu, Q Liu, C Chen, P Lu, X Ding… - Progress in China …, 2023 - Springer
Abstract 9870 thousand people develop tuberculosis (TB) in 2020. Despite being a
preventable as well as curable communicable disease, tuberculosis still is the leading …